SUMO1 and neoplasm: Immunofluorescent analyses of the resultant tumors showed that both sulfopin and RO3306 reduced SUMO1-modied sumoylation in tumor cells, while sulfopin plus RO3306 treatment showed the strongest inhibition on SUMO1-sumoylation (Fig. 7e, f, Supplementary Fig. 5d, e).